JW THERAP-B: Form of proxy for the Annual General Meeting to be held on June 26, 2025
JW THERAP-B: NOTICE OF ANNUAL GENERAL MEETING
JW THERAP-B: PROPOSALS FORGENERAL MANDATES TO ISSUE SHARES, TRANSFER SHARESOUT OF TREASURY AND REPURCHASE SHARESANDRE-ELECTION OF DIRECTORSANDRE-APPOINTMENT OF AUDITORANDNOTICE OF ANNUAL GENERAL MEETING
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
JW THERAP-B: 2024 Environmental, Social and Governance Report
JW THERAP-B: 2024 ANNUAL REPORT
JW THERAP-B: CONNECTED TRANSACTION IN RELATION TO THE LICENSE AGREEMENT AND FURTHER INFORMATION RELATING TOTHE MATERIAL TRANSFER AGREEMENT
JW THERAP-B: GRANT OF SHARE OPTIONS
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
JW THERAP-B: Next Day Disclosure Return
JW THERAP-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024
JW THERAP-B: CONNECTED TRANSACTION IN RELATION TOMATERIAL TRANSFER AGREEMENT
JW THERAP-B: NOTICE OF BOARD MEETING
JW THERAP-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
JW THERAP-B: CHANGE OF CHAIRMAN
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
JW THERAP-B: VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE RECEIPT OF BREAKTHROUGH THERAPY DESIGNATION FOR CARTEYVA IN CHINA AS SECOND-LINE TREATMENT IN RELAPSED OR REFRACTORY ADULT LARGE B-CELL LYMPHOMA
JW THERAP-B: GRANT OF SHARE OPTIONS AND GRANT OF RESTRICTED SHARE UNITS
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024